CytoMed, a Singapore Biotech, Revolutionizes Cancer Treatment Using Donor Immune Cells Press Release CytoMed, a Singapore Biotech, Revolutionizes Cancer Treatment Using Donor Immune Cells Eastern Europe Journal 4 hours ago In Singapore, one biotech company is changing how we approach cancer treatment. CytoMed Therapeutics (NASDAQ: GDTC), just launched its ANGELICA clinical trial, to fundamentally change how we make... Read More
CytoMed, a Singapore Biotech, Revolutionizes Cancer Treatment Using Donor Immune Cells